Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)
血清神经丝轻链和胶质纤维酸性蛋白在稳定期多发性硬化症患者停用一线疾病修饰疗法后检测疾病活动的可靠性（DOT-MS）
期刊:Journal of Neurology
影响因子:4.6
doi:10.1007/s00415-025-13231-9
Fung, W H; Wessels, M H J; Coerver, E M E; de Beukelaar, J; Bouvy, W H; Canta, L R; Gerlach, O H H; Hoitsma, E; Hoogervorst, E L J; de Jong, B A; Kalkers, N F; van Kempen, Z L E; Lövenich, H; van Munster, C E P; van Oosten, B W; Smolders, J; Vennegoor, A; Zeinstra, E M P E; Barrantes-Cepas, M; Kooij, G; Schoonheim, M M; Lissenberg-Witte, B I; Moraal, B; Barkhof, F; Uitdehaag, B M J; Mostert, J; Teunissen, C E; Killestein, J; Strijbis, E M M
